Cytokine Biosensors: the Future of Infectious Disease Diagnosis?

Qing Zhou,Timothy Kwa,Ying Liu,Alexander Revzin

DOI: https://doi.org/10.1586/eri.12.102

2012-01-01

Expert Review of Anti-infective Therapy

Abstract:Why detect cytokines? Blood carries evidence of infections, making blood analysis the first and often the best means of diagnosis. The evidence of infections is stored within memory immune cells that arise during cellular immune response and remain ‘on file’ in case disease reappears at a later time. Hypothetically, all infections eliciting cellular immunity leave behind disease (antigen)-specific Tand B-lymphocytes. These cells may therefore be queried to test for previous exposure to infections. The presence of disease-specific lymphocytes is most frequently determined by monitoring production of cytokines – small signaling proteins released by immune cells in response to antigenic stimulation. The best example of this concept is monitoring IFN-γ for diagnosis of tuberculosis (TB). The methods for direct detection of TB are either time consuming, as is the case with sputum cultures, or expensive, as is the case with x-rays. Therefore, the field relies on indirect measurement of antigenic responses in skin or blood to quickly diagnose latent TB and identify candidates for further analysis. The blood tests, called IFN-γ release assays, are measuring response of antigen-stimulated T cells and are gradually supplanting the traditional tuberculin skin test [1]. IFN-γ release assays are more quantitative and faster than tuberculin skin test, and importantly, are less likely to yield false positive results in individuals vaccinated with Bacille Calmette–Guerin. Beyond detection of IFN-γ, there is a strong interest in profiling other cytokines to discriminate between active and latent stages of TB [2–4]. For example, recent studies have suggested that TNF-α secretion by CD4 T cells can be used to discriminate active and latent TB [3]. Given the ease of access, disease diagnosis based on blood biomarkers such as cytokines is appealing for diseases other than TB. For example, granulocyte-colony stimulating factor and IL-8 were shown to be possible biomarkers of bacteremic pneumonia in acute pneumonia diagnosis. Both of these cytokines are responsible for enhancing the antibacterial activity of neutrophils [5]. In the case of viral infection, multiple studies have described cytokines as correlates of HIV progression or suppression [6]. In these studies, presence of Th1 cytokines, IFN-γ and IL-2 was associated with suppression of HIV and was observed in long-term nonprogressors, whereas Th2 cytokines were associated with rapid disease progression. Monitoring the dynamics of proinflammatory and anti-inflammatory cytokines may also be important for cytokine-interference therapy for HIV infection, assisting in lowering the viral setpoint in patients [7]. For parasite infection, cytokines also have an appreciable impact: the polarization to Th2 response in severe malaria infection usually results in higher serum levels of TNF-α in conjunction with lower IL-12 and IFN-γ levels. Therefore, serum TNF-α level can assist in predicting fatal outcomes [8]. Cytokine biosensors: the future of infectious disease diagnosis?